semaglutide autoimmune disease GLP-1 Drugs Lower Risk of Death by 44% in Obesity and 6 weeks micro dosing Semaglutide

GLP-1 Injections & Semaglutide GLP-1 Injections & Semaglutide Semaglutide is one of the latest weight loss medications approved by the FDA

The FDA has received reports of at least 20 cases of ileus, including two deaths, among people taking Ozempic

This publication suggested a potential role for liraglutide in the prevention and stabilization of atherosclerotic vascular disease, together with possible protection against major CV events

Pharmacological inhibition of TGF-RI (e.g., RepSox) promotes brown adipogenesis via UCP1 upregulation, preventing obesity (Tu et al

Benny B, Antony B

Thiazolidinediones (e.g., pioglitazone): these improve insulin sensitivity but have specific contraindications and precautions